Presentation - SLING Diffusion

hordeprobableBiotechnology

Oct 4, 2013 (3 years and 10 months ago)

82 views

The

SLING Project

Background

Our Objectives Today

The SLING project is funded by the European Commission within Research Infrastructures of the
FP7 Capacities Specific Programme, grant agreement number 226073 (Integrating Activity)

Alicante, September 29, 2011

Gerard Giroud, SLING Senior Consultant

1

European Union
Policy

2

Lisbon Agenda /Europe 2020


European Research Area

Research Infrastructures
(ESFRI)




biological
information
(
ELIXIR)

Biotechnology
program

FP7 (SLING)

ESFRI

European Strategy Forum on Research and
Innovation


35

pan
-
European research
infrastructures
identified


ELIXIR
is one of them, for
biomolecular data


It will construct
, operate and enhance a
distributed research
infrastructure


Governance: ELIXIR board


The

ELIXIR Hub connected
to

ELIXIR Nodes


To
provide infrastructure
for data, compute,
tools, standards and training.


3

ELIXIR




4

The Funding
Model


So far 5 Countries


Denmark,

Finland,

the
Netherlands
,

Sweden,

the
United
Kingdom


have signed a MOU with
EBML/EBI

ELIXIR


National Nodes:


54 Organizations in 23
countries interested


ES node candidates:


Fundacion

Centro Nacional
De Investigaciones
Oncologi
, Madrid (
CNIO
)


Universitat
Autònoma de
Barcelona

(
UAB
)


5

gotomap

6

7

8

Biotechnology Infrastructure


In 2006 the EU awarded 16.7 million Euros



ensure long
-
term support of several European
bioinformatics databases and developments.



The funding was the largest bioinformatics
infrastructure award ever granted in Europe.



9

2 Projects: FELICS and SLING


FELICS:
Free European Life
-
science Information and
Computational Services


SLING:
Serving Life Science for the Next Generation


They aimed to maintain a number of key
resources in biological databases and
bioinformatics tools


EPO ensures that the bio
-
molecular
information from patents is covered in all
databases


10

Some Results available


XML standard for biological sequence presentation



Sequences Filing software BISSAP



Non redundant Patent sequence database



Initiating a collection of chemical entities disclosed in
patents





11

12

Dissemination of knowledge

1.

Comprehensive Databases in Biotechnology


2.

Broad Use of the Databases and the Search
Tools


3.

New submission tool for biological sequences


4.
IP awareness in Biotechnology,

13

Comprehensive Databases in Biotechnology

14

CC

Year

TOTAL Biotechnology papers

Spain

2000

6.460

2001

6.484

2002

6.887

2003

7.578

2004

8.042

2005

8.859

2006

9.359

2007

9.530

16

CC

Year

TOTAL Biotechnology
papers

Spain

2000

6.460

2001

6.484

2002

6.887

2003

7.578

2004

8.042

2005

8.859

2006

9.359

2007

9.530

TOTAL Biotechnology
patent
applications

81

110

96

105

114

94

119

202

CONCLUSIONS



Comprehensive Databases in Biotechnology

Your contribution: Patent Offices, Universities, Industry




Broad Use of the Databases and the Search
Tools

Learn about the tools available to you: free!



New submission tool for biological sequences

BISSAP will be presented to you; try it!


IP awareness in Biotechnology

Valorize your research?

Use the Patent Documentation in DBs!

18


Thank You!




Gerard
Giroud

Sling Senior Consultant







ggiroud@inode.at

Tel. +43 676 69 24 594

http://at.linkedin.com/in/gerardgiroud


Fax. +43 1 890 55 43


19